Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

2.2K
This protocol demonstrates the workflow of the SILICOFCM platform for automatically generating a parametric model of the left ventricle from patient-specific ultrasound images by applying a multi-scale electromechanical model of the heart. This platform enables in silico clinical trials intended to reduce real clinical trials and maximize positive therapeutic...
2.2K
Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

398
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
398
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

The Journal of infectious diseasesยท2000
Same author

[Recurrent spontaneous carotid dissection].

Revista de neurologiaยท2000
Same author

Safety and efficacy of Omniscan (gadodiamide injection) at 0.1 mmol/kg for MRI in infants younger than 6 months of age: phase III open multicenter study.

Investigative radiologyยท2000
Same author

Percutaneous vertebroplasty: a special syringe for cement injection.

AJNR. American journal of neuroradiologyยท2000
Same author

OESCLIM: an advanced delivery system for HRT.

Maturitasยท2000
Same author

Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systems.

Synapse (New York, N.Y.)ยท2000
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseauxยท2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseauxยท2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseauxยท2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseauxยท2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseauxยท2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseauxยท2010
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

[Primary prevention trial. Methodological problems].

A Munoz

    Archives Des Maladies Du Coeur Et Des Vaisseaux
    |September 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Primary prevention trials are crucial for evaluating lipid metabolism interventions. These studies require large patient cohorts and long follow-up periods, presenting significant logistical challenges.

    More Related Videos

    Clinical Trials
    01:16

    Clinical Trials

    10.2K
    Clinical Trials: Overview
    01:11

    Clinical Trials: Overview

    4.6K

    Related Experiment Videos

    Last Updated: Jan 20, 2026

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    2.2K
    Clinical Trials
    01:16

    Clinical Trials

    10.2K
    Clinical Trials: Overview
    01:11

    Clinical Trials: Overview

    4.6K

    Area of Science:

    • Lipid metabolism research
    • Clinical trial design
    • Preventive medicine

    Context:

    • Primary prevention trials are essential for assessing the efficacy of medical interventions targeting lipid metabolism abnormalities.
    • Conducting these trials involves significant logistical complexities due to the large number of patients and extended follow-up durations required.

    Purpose:

    • To highlight the critical role of primary prevention trials in validating lipid-altering medical interventions.
    • To underscore the methodological requirements for robust clinical trials in this field.

    Summary:

    • Primary prevention trials offer the most reliable evidence for the effectiveness of interventions aimed at correcting lipid metabolism disorders.
    • Successful trials necessitate precise definition of the study population and adherence to the 'one question, one study' principle.

    Impact:

    • Provides a framework for designing and interpreting future lipid metabolism intervention studies.
    • Emphasizes the importance of rigorous methodology in clinical research for public health.
    • Informs healthcare providers and policymakers about the evidence base for lipid-modifying therapies.